INS and obesity disorder: Although, in vitro models of obesity, it has been demonstrated that chemical chaperones and/or overexpression of ER chaperone ORP150 may potentially alleviate insulin signaling and insulin sensitivity (Ozawa et al., 2005; Özcan et al., 2006).